References

CB2R promotes T cell gut homing and exacerbates ileitis in a murine Crohn’s model

10.1093/ibd/izag066 · 2026 · External reference

Treatment of active Crohn’s disease with MLN0002, a humanized antibody to the alpha4beta7 integrin

10.1016/j.cgh.2008.06.007 · 2008 · External reference

Natalizumab for active Crohn’s disease

10.1056/nejmoa020732 · 2003 · External reference

Cannabinoid receptor-2 ameliorates inflammation in murine model of Crohn’s disease

10.1093/ecco-jcc/jjx096 · 2017 · External reference

Manipulation of the endocannabinoid system in colitis: a comprehensive review

10.1097/mib.0000000000001004 · 2017 · External reference

The impact of cannabis use on clinical outcomes in inflammatory bowel disease: a population-based longitudinal cohort study

10.1093/ibd/izad151 · 2024 · External reference

Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn’s disease

10.1097/01.mib.0000440982.79036.d6 · 2014 · External reference

Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study

10.1016/j.cgh.2013.04.034 · 2013 · External reference

Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: a randomized controlled trial

10.1371/journal.pone.0246871 · 2021 · External reference